Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Sonoma Pharmaceuticals, Inc. | Financial_Report.xls |
| S-1/A - S-1/A - Sonoma Pharmaceuticals, Inc. | oculus_s1a1.htm |
| EX-4.19 - FORM OF WARRANT AGREEMENT - Sonoma Pharmaceuticals, Inc. | oculus_s1a1-ex0419.htm |
| EX-5.1 - OPINION OF TROMBLY BUSINESS LAW, PC. - Sonoma Pharmaceuticals, Inc. | oculus_s1a1-ex0501.htm |
| EX-4.20 - UNDERWRITER WARRANT - Sonoma Pharmaceuticals, Inc. | oculus_s1a1-ex0420.htm |
| EX-1.1 - FORM OF UNDERWRITING AGREEMENT - Sonoma Pharmaceuticals, Inc. | oculus_s1a1-ex101.htm |
EXHIBIT 23.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the inclusion in this Registration Statement of Oculus Innovative Sciences, Inc. on Amendment No. 1 to Form S-1 (File No. 333-200461) of our report dated June 30, 2014 with respect to our audits of the consolidated financial statements of Oculus Innovative Sciences, Inc. and Subsidiaries as of March 31, 2014 and 2013 and for the years then ended, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Marcum LLP
Marcum LLP
New York, NY
January 7, 2015